Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0DAUKA
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Polatuzumab-compound (XV)
|
|||||
| Synonyms |
Polatuzumab Compound (XV)
Click to Show/Hide
|
|||||
| Organization |
Orum Therapeutics, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Diffuse large B-cell lymphoma [ICD11:2A81]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1-2
|
|||||
| Structure |
|
|||||
| Antibody Name |
Polatuzumab
|
Antibody Info | ||||
| Antigen Name |
B-cell antigen receptor complex-associated protein beta chain (CD79B)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Polatuzumab-Compound (XV) linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.